Evidence map›Paper›PMID 11023839›Full record

ArticleThe Biochemical journal2000

The biochemical characterization of aggrecan from normal and tibial-dyschondroplastic chicken growth-plate cartilage.

C Tselepis, A P Kwan, D Thornton, J Sheehan

Open access · greenAbstract readComparative Study
In one paragraph

Article in The Biochemical journal, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

C TselepisWellcome Trust Centre for Cell-Matrix Research, School of Biological Sciences, University of Manchester, Manchester M13 9PT, UK. christ@cancer.bham.ac.uk
A P Kwan
D Thornton
J Sheehan
Wellcome Centre for Cell-Matrix Research · GBCardiff Story Museum · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tibial dyschondroplasia (TD) is a disorder of endochondral ossification characterized by the presence of an avascular, non-mineralized cartilage lesion extending from the growth plate into the metaphysis. Cells within the TD growth plate fail to differentiate to full hypertrophy, and instead appear to maintain a 'pre-hypertrophic' or 'transitional' status. Studies of the expression and distribution of cartilage matrix macromolecules in the TD growth plate have shown a marked decrease in the levels of aggrecan in the TD matrix. In the present study we compared the biochemical characteristics of the aggrecan molecules extracted from normal epiphyseal and TD cartilage. We have shown three major differences between normal and TD cartilage aggrecan. These are: (1) increase in molecular mass; (2) increase in the number of keratan sulphate chains; and (3) difference in the pattern of sulphation in TD aggrecan. Such changes in biochemical characteristics of the aggrecan monomers in TD cartilage may be associated with the lack of mineralization of the diseased cartilage. The present study provides a basis for further investigations into the importance of proteoglycans in normal and pathological bone development.

Indexed as

Extracellular Matrix ProteinsGlycoside HydrolasesAggrecansAnimalsbeta-GalactosidaseBlotting, WesternCattleChickensChondroitinases and Chondroitin LyasesChromatography, GelElectrophoresis, Agar GelEpitopesGrowth PlateKeratinsLectins, C-TypeLightAggrecansbeta-GalactosidaseChondroitinases and Chondroitin LyasesEpitopesExtracellular Matrix ProteinsGlycoside Hydrolaseskeratan-sulfate endo-1,4-beta-galactosidaseKeratinsLectins, C-TypeProteoglycansSulfates

Identifiers

PMID11023839
PMCPMC1221389
OpenAlexW2116249068

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.